Do triglyceride-rich lipoprotein remnants penetrate the arterial wall, trigger endothelial inflammation, and reduce nitric oxide–mediated vasodilation?

The impact of triglyceride-rich lipoproteins (TRLs) and their remnants on vascular health is a critical factor in the progression of atherosclerosis, particularly in older populations where existing endothelial vulnerability may be present.

Arterial penetration and retention

Current research confirms that TRL remnants, specifically those under 70–80 nm in diameter, readily penetrate the arterial intima through transcytosis or paracellular pathways. While large chylomicrons are typically excluded, their lipolysis products (remnants) are small enough to enter the subendothelial space. Once inside, these particles are often more atherogenic than LDL because their high content of apolipoprotein E and C-III increases their binding affinity for the subendothelial proteoglycan matrix, leading to significant sequestration within the vessel wall.

Endothelial inflammation

TRL remnants act as potent inflammatory stimuli. Upon entering the subendothelial space, they activate the NF-κB signaling pathway, which triggers the release of pro-inflammatory cytokines like TNF-α and IL-6. This process upregulates adhesion molecules, including ICAM-1 and VCAM-1, which are essential for recruiting monocytes to the arterial wall. Mechanistically, this is driven by the generation of reactive oxygen species (ROS) and the release of bioactive oxylipins during the lipolysis of TRLs.

Reduction of nitric oxide bioavailability

TRLs significantly impair vasomotor function by reducing the bioavailability of nitric oxide (NO). This occurs through two primary mechanisms:

• Inhibition of synthesis: Remnants induce oxidative stress that inhibits endothelial nitric oxide synthase (eNOS) activity, reducing the actual production of NO.
• Active scavenging: In the plasma and subendothelial space, TRL surges can increase NO autoxidation by approximately 48-fold, effectively quenching NO before it can reach vascular smooth muscle.

Clinical studies using flow-mediated dilation (FMD) consistently show an inverse relationship between postprandial remnant levels and the ability of the vessel to dilate. This effect is particularly pronounced in postmenopausal women, such as those aged 70, who have lost the protective endothelial effects of estrogen.

Bottom line

Triglyceride-rich remnants are highly atherogenic particles that penetrate the arterial wall, trigger localized inflammation via NF-κB activation, and impair vasodilation by both inhibiting nitric oxide production and accelerating its degradation.